Echocardiographic Evaluation of Qiangxin Decoction Combined with Cardiac Resynchronization Therapy for Patients with Chronic Heart Failure  

作　　者：Wei Yunfeng Guo Daoning Zou Xiaopan Ding Qian 卫云峰;郭道宁;邹晓攀;丁倩(Department of Ultrasound, Mianyang Central Hospital)

机构地区：[1]Department of Ultrasound, Mianyang Central Hospital

出　　处：《World Journal of Integrated Traditional and Western Medicine》2019年第3期7-11,共5页世界中西医结合杂志（英文）

摘　　要：OBJECTIVE: To explore the echocardiographic evaluation of patients with chronic heart failure (CHF) after Qiangxin Decoction combined with cardiac resynchronization therapy. METHODS: A total of 140 CHF patients admitted to our hospital were randomly divided into combined group (Qiangxin Decoction and cardiac resynchronization, n = 70) and routine group (cardiac resynchronization, n = 70), and they were treated for 2 courses (16 weeks), with 8 weeks as a course. The improvement of heart function classification (HYHA) was observed before and after treatment, and the therapeutic effects were evaluated according to the improvement of heart function classification (markedly effective, effective, invalid, and worsening). The traditional Chinese medicine (TCM) diagnostic criteria was the main symptoms (0 to 6 points), secondary symptoms (0 to 3 points), tongue picture (0 to 1 point) and pulse condition (0 to 1 point), and the higher the score was, the more obvious the symptoms were. The left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular ejection fraction (LVEF) and cardiac output (CO) were observed and recorded according to the heart color ultrasound before and after treatment. And the Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used to evaluate the life quality before and after treatment, and the highest score of the scale was 105 points. The higher the score was, the obvious the symptoms were, and the worse the life quality was. And the adverse reactions were recorded in the 2 groups. RESULTS: After the treatment, the total effective rate in the routine group was significantly lower than that in the combined group (75.71% vs . 94.30%), and there was statistically significant difference (P < 0.05). After the treatment, the TCM syndrome score in the routine group was higher than that in the combined group ((14.37±3.59) points vs.(10.53±3.11) points), and there was statistically significant difference (P < 0.05). After the treatment, the lOBJECTIVE: To explore the echocardiographic evaluation of patients with chronic heart failure(CHF) after Qiangxin Decoction combined with cardiac resynchronization therapy. METHODS: A total of 140 CHF patients admitted to our hospital were randomly divided into combined group(Qiangxin Decoction and cardiac resynchronization, n = 70) and routine group(cardiac resynchronization, n = 70), and they were treated for 2 courses(16 weeks), with 8 weeks as a course. The improvement of heart function classification(HYHA) was observed before and after treatment, and the therapeutic effects were evaluated according to the improvement of heart function classification(markedly effective, effective, invalid, and worsening). The traditional Chinese medicine(TCM) diagnostic criteria was the main symptoms(0 to 6 points), secondary symptoms(0 to 3 points), tongue picture(0 to 1 point) and pulse condition(0 to 1 point), and the higher the score was, the more obvious the symptoms were. The left ventricular end-diastolic diameter(LVEDD), left ventricular end-systolic diameter(LVESD), left ventricular ejection fraction(LVEF) and cardiac output(CO) were observed and recorded according to the heart color ultrasound before and after treatment. And the Minnesota Living with Heart Failure Questionnaire(MLHFQ) was used to evaluate the life quality before and after treatment, and the highest score of the scale was 105 points. The higher the score was, the obvious the symptoms were, and the worse the life quality was. And the adverse reactions were recorded in the 2 groups. RESULTS: After the treatment, the total effective rate in the routine group was significantly lower than that in the combined group(75.71% vs. 94.30%), and there was statistically significant difference(P < 0.05). After the treatment, the TCM syndrome score in the routine group was higher than that in the combined group((14.37±3.59) points vs.(10.53±3.11) points), and there was statistically significant difference(P < 0.05). After the treatment, the levels of LVEDD and LV

关 键 词：Qiangxin DECOCTION CARDIAC RESYNCHRONIZATION therapy Chronic heart failure ECHOCARDIOGRAM TCM syndrome SCORE 

分 类 号：R[医药卫生]